CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant

GlobeNewswire•March 12, 2019 OXNARD, Calif., March 12, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement Administration (DEA) license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol (CBD). This license allows CURE…

Details

March 12, 2019

Energy Fuels Announces 2018 Results

PR Newswire•March 12, 2019 LAKEWOOD, CO, March 12, 2019 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), today reported its financial results for the year ended December 31, 2018. The Company’s Annual Report on Form 10-K has been filed with the U.S. Securities and Exchange Commission (“SEC”), and may…

Details

March 12, 2019

Wealth Closes $1.35m Loan

GlobeNewswire•March 6, 2019 VANCOUVER, British Columbia, March 06, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN), reports it has closed its loan placement, as announced on February 11, 2019, to third-party lenders as well as an insider. The total loan sum closed is…

Details

March 6, 2019

Wealth Receives Positive Geophysical Results for the Vapor Lithium Brine Project, Northern Chile and Provides Corporate Update

GlobeNewswire•February 28, 2019 VANCOUVER, British Columbia, Feb. 28, 2019 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: WMLLF; SSE: WMLCL; Frankfurt: EJZN), reports that it has received positive results from geophysical surveys conducted on and around certain concessions in the Company’s Vapor project (the “Vapor Project”), located in the…

Details

February 28, 2019

Energy Fuels Producing Vanadium at Commercial Levels; Vanadium Shipments Commenced

CNW Group•February 12, 2019 LAKEWOOD, CO , Feb. 12, 2019 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium and vanadium in the United States , is pleased to announce that it is now producing high-purity vanadium at commercial rates of approximately 175,000 to 200,000…

Details

February 13, 2019

National Healthcare Economics and Policy Expert Ruben Jose King-Shaw Jr Joins CURE Pharmaceutical’s Board of Directors

GlobeNewswire• January 29, 2019 The drug delivery leader taps former COO of U.S. Centers for Medicare & Medicaid Services to join growing Board OXNARD, Calif., Jan. 29, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced Ruben Jose King-Shaw Jr. has joined its Board of Directors. King-Shaw brings…

Details

January 29, 2019

Energy Fuels Commencing Vanadium Production; Testing New Approaches to Mining in Tight Vanadium Market

LAKEWOOD, CO, Sept. 27, 2018 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”) is pleased to announce that the Company expects to resume vanadium production at its 100% owned White Mesa Mill (the “Mill”) in mid-November 2018, producing significant quantities of salable V2O5 product by the end of…

Details

September 27, 2018

CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules

CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, announced the allowance of an oral thin film patent (U.S. Patent No. 10092611), which covers the processing and integration of bioactive cannabinoid molecules into oral thin film dosage forms, such as CUREfilm(TM), the most advanced oral thin film on the market today. These molecules such…

Details

September 25, 2018